Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Nov 5;8(21):e012596.
doi: 10.1161/JAHA.119.012596. Epub 2019 Oct 28.

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

Daniele Pastori  1 , Emilia Antonucci  2 , Francesco Violi  1 , Gualtiero Palareti  2 , Pasquale Pignatelli  1 ; START2 Registry Investigators ‡; START2 Registry Investigators<xref ref-type="author-note" rid="jah34460-note-1002"><sup>‡</sup></xref>
Collaborators, Affiliations
Multicenter Study

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

Daniele Pastori et al. J Am Heart Assoc. .

Abstract

Background Thrombocytopenia is associated with increased mortality in the general population, but few data exist in patients with atrial fibrillation (AF) taking oral anticoagulants. We investigated factor determinants of thrombocytopenia in a large cohort of patients affected by AF and its association with total mortality. Methods and Results Multicenter prospective cohort study, including 5215 patients with AF from the START (Survey on Anticoagulated Patients Register) registry, 3877 (74.3%) and 1338 (25.7%) on vitamin K or non-vitamin K antagonist oral anticoagulants, respectively. Thrombocytopenia was defined by a platelet count <150×109/L. Determinants of thrombocytopenia were investigated, and all-cause mortality was the primary survival end point of the study. Thrombocytopenia was present in 592 patients (11.4%). At multivariable logistic regression analysis, chronic kidney disease (odds ratio [OR], 1.257; P=0.030), active cancer (OR, 2.065; P=0.001), liver cirrhosis (OR, 7.635; P<0.001), and the use of diuretics (OR, 1.234; P=0.046) were positively associated with thrombocytopenia, whereas female sex (OR, 0.387; P<0.001) and the use of calcium channel blockers (OR, 0.787; P=0.032) were negatively associated. During a median follow-up of 19.2 months (9942 patient-years), 391 deaths occurred (rate, 3.93%/year). Mortality rate increased from 3.8%/year to 9.9%/year in patients with normal platelet count and in those with moderate-severe thrombocytopenia, respectively (log-rank test, P=0.009). The association between moderate-severe thrombocytopenia and mortality persisted after adjustment for CHA2DS2 VASc score (hazard ratio, 2.431; 95% CI, 1.254-4.713; P=0.009), but not in the fully adjusted multivariable Cox regression analysis model. Conclusions Thrombocytopenia is common in patients with AF. Despite an increased incidence of mortality, thrombocytopenia was not associated with mortality at multivariable analysis. Thrombocytopenia may reflect the presence of comorbidities associated with poor survival in AF.

Keywords: atrial fibrillation; mortality; thrombocytopenia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan‐Meier curves for risk of mortality, according to the presence of thrombocytopenia.
See this image and copyright information in PMC

References

    1. Fountain EM, Arepally GM. Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis. 2017;43:429–436. - PubMed
    1. Bonaccio M, Di Castelnuovo A, Costanzo S, De Curtis A, Donati MB, Cerletti C, de Gaetano G, Iacoviello L, Moli‐sani I. Age‐ and sex‐based ranges of platelet count and cause‐specific mortality risk in an adult general population: prospective findings from the Moli‐sani study. Platelets. 2018;29:312–315. - PubMed
    1. Leader A, Ten Cate H, Spectre G, Beckers EAM, Falanga A. Antithrombotic medication in cancer‐associated thrombocytopenia: current evidence and knowledge gaps. Crit Rev Oncol Hematol. 2018;132:76–88. - PubMed
    1. Yadav M, Genereux P, Giustino G, Madhavan MV, Brener SJ, Mintz G, Caixeta A, Xu K, Mehran R, Stone GW. Effect of baseline thrombocytopenia on ischemic outcomes in patients with acute coronary syndromes who undergo percutaneous coronary intervention. Can J Cardiol. 2016;32:226–233. - PubMed
    1. Park J, Cha MJ, Choi YJ, Lee E, Moon I, Kwak S, Kwon S, Yang S, Lee S, Choi EK, Oh S. Prognostic efficacy of platelet count in patients with nonvalvular atrial fibrillation. Heart Rhythm. 2019;16:197–203. - PubMed

Publication types

LinkOut - more resources